Philadelphia Multiple Myeloma Networking Group (PMMNG)

09/01/2026

📢 September PMMNG Virtual Meeting

🗓️ Date: September 19, 2026, 1:30 - 3:00 PM
🗣️ Topic: Open Meeting
🎙️ Presenter: Whole Group
🌐 Details: Visit our website philadelphia.myeloma.org
📝 Summary: This will be an open meeting to discuss your myeloma journey

08/17/2026

Protecting Your Kidneys During Myeloma Care: Imaging Considerations

Learn which imaging tests and cancer treatments are safe and effect...

08/17/2026

07/22/2026

One of my favorite things about the newly published ENDURANCE trial in The New England Journal of Medicine isn’t just the science—it’s seeing the smiles on the faces of the myeloma experts discussing it. 😊

Patients have been asking for years:
“Do I really have to stay on maintenance forever?”

Now we finally have randomized data to help answer that question for many standard-risk patients who did not undergo an upfront stem cell transplant. The excitement is contagious because this isn’t just about fewer pills—it’s about fewer side effects, less treatment burden, and more informed, shared decision-making. https://www.nejm.org/doi/full/10.1056/NEJMoa2600157

Sometimes the best research doesn’t add more treatment… it shows us when less may be enough.

I have to admit—it makes me smile that the doctors seem just as happy about these results as the patients. ❤️

02/28/2025

In this HealthTree University video lesson you will learn why your treatment stops work leading to relapse.

Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversityCreate a free account to track your progress, bookmark less...

02/15/2025

Did you know there are 2 types of relapses in myeloma? In this HealthTree University video both types of relapses are explained by leading myeloma specialists as well as when treatment should resume. .

Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversityCreate a free account to track your progress, bookmark less...

08/10/2023

https://www.prnewswire.com/news-releases/us-fda-approves-talvey-talquetamab-tgvs-a-first-in-class-bispecific-therapy-for-the-treatment-of-patients-with-heavily-pretreated-multiple-myeloma-301897786.html

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted...

07/12/2023

The role of imaging in MRD testing.

Learn about how imaging plays a role in MRD testing.Get exclusive access to the latest content as soon as it's filmed at https://www.healthtree.org/myeloma/u...

07/08/2023

To all of the PMMNG family and friends,

Welcome summer!

Our next monthly PMMNG meeting will be held Saturday, July 8, 2023 from 1:30-3:00 PM ET. The meeting will be conducted via Zoom. See below for the link.

We will be breaking out into small groups at the beginning of the meeting, followed by the presentation by Dr Faiman. You will have an opportunity to address specific issues and questions in the small groups.

Beth Faiman will be presenting on the topic of “Updates in Bone Health” including updates in medications, timing, and how to optimize bone health in myeloma.

If you are new to the group, contact Barbara Falkowitz ([email protected]) to receive the meeting link.

07/08/2023

An oldie, but goodie - All About Dexamethasone

Get exclusive access to the latest content as soon as it's filmed at https://www.healthtree.org/myeloma/university HealthTree University for Multiple Myeloma...